Literature DB >> 3167832

Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.

B E Miller1, F R Miller, D Wilburn, G H Heppner.   

Abstract

When mixtures of cell lines 168 and 4T07, both derived from the same mouse mammary tumor, were injected into syngeneic mice, the resulting tumors, analyzed over a large size range by colony-forming assays in selective media, consisted primarily of line 4T07, even when the ratio injected was 100:1 or greater in favor of line 168. This result indicated a suppression of growth of line 168, since the volume-doubling time of line 168 tumors in the absence of line 4T07 was one-half that of line 4T07 tumors. That growth suppression was not due to inhibition of line 168 by immunity induced to line 4T07 was shown in two ways: (a) line 168 tumors grew almost as well in mice preimmunized with line 4T07 as in controls, whereas line 4T07 tumor growth was strongly inhibited in preimmunized mice; and (b) the final composition (favoring line 4T07) in mixed tumors was similar in tumors grown in mice immunosuppressed by irradiation to that in nonirradiated controls. The strong suppression of line 168 did not occur when the two cell lines were injected simultaneously at different s.c. sites, nor did it occur when line 168 cells were injected in mixtures with lethally irradiated line 4T07 cells. Line 4T07 cells also suppressed the growth of line 168 cells in monolayer cultures. It was not likely that suppression was due to competition for growth factors, since the effect required cell contact. Suppression probably was not mediated through junctional communication, since these cells do not engage in metabolic cooperation. We suggest that a growth-inhibitory factor produced by line 4T07 mediates the suppression of 168 cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167832

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Inhibition of lung colonization at two different steps in the metastatic sequence.

Authors:  C J Aslakson; D McEachern; D H Conaway; F R Miller
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

Authors:  Seung Woo Cho; Jin Xu; Ruping Sun; Maxwell R Mumbach; Ava C Carter; Y Grace Chen; Kathryn E Yost; Jeewon Kim; Jing He; Stephanie A Nevins; Suet-Feung Chin; Carlos Caldas; S John Liu; Max A Horlbeck; Daniel A Lim; Jonathan S Weissman; Christina Curtis; Howard Y Chang
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

Review 3.  Tumorigenesis: it takes a village.

Authors:  Doris P Tabassum; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2015-07-02       Impact factor: 60.716

Review 4.  Breast cancer complexity: implications of intratumoral heterogeneity in clinical management.

Authors:  Brittany Haynes; Ashapurna Sarma; Pratima Nangia-Makker; Malathy P Shekhar
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

5.  A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis.

Authors:  Elvin Wagenblast; Mar Soto; Sara Gutiérrez-Ángel; Christina A Hartl; Annika L Gable; Ashley R Maceli; Nicolas Erard; Alissa M Williams; Sun Y Kim; Steffen Dickopf; J Chuck Harrell; Andrew D Smith; Charles M Perou; John E Wilkinson; Gregory J Hannon; Simon R V Knott
Journal:  Nature       Date:  2015-04-08       Impact factor: 49.962

6.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

Review 7.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 8.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

Review 9.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

Review 10.  Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.

Authors:  J Guy Lyons; Erwin Lobo; Anna M Martorana; Mary R Myerscough
Journal:  Clin Exp Metastasis       Date:  2007-12-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.